RELATIONSHIP BETWEEN LANGUAGE-LITERACY SKILLS AND MENTAL HEALTH
RESEARCHER PROFILE (Filmed April 2024)
Associate Professor Amanda Neil
Select Foundation Principal Research Fellow
Menzies Institute for Medical Research
University of Tasmania &
Health Economics Lead,
Alive National Centre for Mental Health Research Translation
Australia
A/Prof Amanda Neil is a Select Foundation Principal Research Fellow, Menzies Institute for Medical Research, and the health economics lead for the ALIVE National Centre for Mental Health Research Translation. Amanda commenced work in the field of health economics in 1991, and has worked in academia, government and for industry. She was a Member of the Pharmaceutical Benefits Advisory Committee Economics Sub-Committee between 2000 and 2007.
Since commencing at Menzies in 2013, Amanda has established a research program focused on health services and systems, including innovative funding mechanisms and service provision within Tasmania. In 2019, Amanda established the Menzies Mental Health and Wellbeing Research Group to support university and sector wide mental health research in Tasmania. These efforts now include a collaboration with the recently established Tasmanian Centre for Mental Health Service Innovation, including on the current project.
In an innovative move towards enhancing mental health services, Associate Professor Amanda Neil and team, supported by the RHH Research Foundation, are undertaking a crucial study on language-literacy skills of patients within mental health care settings. This year-long project, which commenced in April 2024, seeks to unravel to what extent, where and for whom language-literacy skills are being considered in Tasmanian mental health service provision.
The current project is one Amanda is very passionate about, given her own experience as the mum of a child who experienced significant delays in learning to speak, read and write. This experience leading to her involvement in the 2017 and 2018 Heart of Literacy Symposiums led by 2017 Tasmanian of the Year, Ms Rosalie Martin. Subsequently, A/Prof Isabelle Bartkowiak-Theron, Tasmanian Institute of Law Enforcement and Amanda received philanthropic funding to establish a research program on language-literacy as a social determinant of health and a pathway to resilience and desistence. The current project is extending this foundational work into the domain of mental health service provision.
-
Investigating the benefits of donor human milk for preterm infants
Together, SAHMRI and Lifeblood are leading a consortium to revolutionise the way human milk, and novel products made from human milk, are used as nutritional and medical interventions to improve health outcomes in vulnerable infants, but with potential application for a diverse range of medical indications.
Currently, babies who are born early preterm – before 32 weeks – are given donor milk when their own mother’s milk is not available or in short supply. Whether donor milk is beneficial for babies born just a few weeks early is unclear, as very little research has been undertaken with these babies.
The GIFT Trial will soon commence as an investigation between SAHMRI, the University of Adelaide, the Red Cross Lifeblood Milk Bank conducted at five sites across three states in Australia.
-
CASE STUDY Large scale genetic study finds link between Irritable Bowel Syndrome & cardiovascular system
Research published April 2024 in the journal Cellular and Molecular Gastroenterology and Hepatology sheds light on disease mechanisms common to irritable bowel syndrome (IBS) and cardiovascular diseases (CVD).
-
Patient reported outcomes in the diagnosis and treatment of lymphoma
Dr. Elizabeth Goodall (BMedSci Hons, MBBS Hons, FRACP, FRCPA) is a PhD student and early career researcher with La Trobe University and the Olivia Newton John Cancer Research Institute (ONJCRI), and Haematologist at Austin Health and Monash Health, Melbourne.
Her specific interest in how patients experience their illness and treatment forms the basis for her research in improving patient outcomes. This research comes at a pivotal time in modern lymphoma management with an ever-increasing number of treatment options available and renewed focus on each patient’s journey.
